Screening of a new class of Janus kinase 3 inhibitors targeted at its non-kinase domain

被引：0
|
作者：
Mishra, Jayshree
Das, Jugal Kishore
Kumar, Narendra
机构：
来源：
FASEB JOURNAL | 2018年 / 32卷 / 01期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
836.4
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Development of Selective Covalent Janus Kinase 3 Inhibitors
    Tan, Li
    Akahane, Koshi
    McNally, Randall
    Reyskens, Kathleen M. S. E.
    Ficarro, Scott B.
    Liu, Suhu
    Herter-Sprie, Grit S.
    Koyama, Shohei
    Pattison, Michael J.
    Labella, Katherine
    Johannessen, Liv
    Akbay, Esra A.
    Wong, Kwok-Kin
    Frank, David A.
    Marto, Jarrod A.
    Look, Thomas A.
    Arthur, J. Simon C.
    Eck, Michael J.
    Gray, Nathanael S.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (16) : 6589 - 6606
  • [22] Venous thromboembolism risk with Janus kinase inhibitors: Is it a class wide effect?
    Jubber, Ameen
    Woodward, Jonathan
    Tahir, Hasan
    Moorthy, Arumugam
    EXPERT OPINION ON DRUG SAFETY, 2022, 21 (08) : 1005 - 1007
  • [23] Janus Kinase Inhibitors and Non-Melanoma Skin Cancer
    Greif, Charlotte S.
    Srivastava, Divya
    Nijhawan, Rajiv I.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (02)
  • [24] Janus Kinase Inhibitors and Non-Melanoma Skin Cancer
    Charlotte S. Greif
    Divya Srivastava
    Rajiv I. Nijhawan
    Current Treatment Options in Oncology, 2021, 22
  • [25] Developing selective PI3K degraders to modulate both kinase and non-kinase functions
    Zimo Yang
    Yan Tong
    Yongbo Liu
    Qianlong Liu
    Zhihao Ni
    Yuna He
    Yu Rao
    Chinese Chemical Letters, 2024, 35 (11) : 411 - 415
  • [26] Comprehensive Data-Driven Assessment of Non-Kinase Targets of Inhibitors of the Human Kinome
    Mobasher, Mona
    Vogt, Martin
    Xerxa, Elena
    Bajorath, Juergen
    BIOMOLECULES, 2024, 14 (03)
  • [27] Effect of non-kinase activity of myosin light chain kinase (MLCK) on smooth muscle myosin and its fragment
    Liang, ML
    Gao, Y
    Arai, K
    Nakamura, A
    Kohama, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 242P - 242P
  • [28] Janus kinase inhibitors: an update on the progress and promise of targeted therapy in the myeloproliferative neoplasms
    Stein, Brady L.
    Crispino, John D.
    Moliterno, Alison R.
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (06) : 609 - 616
  • [29] Janus Kinase Inhibitors: A New Tool for the Treatment of Axial Spondyloarthritis
    Paroli, Marino
    Caccavale, Rosalba
    Paroli, Maria Pia
    Spadea, Luca
    Accapezzato, Daniele
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (02)
  • [30] Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3)
    Clark, Michael P.
    George, Kelly M.
    Bookland, Roger G.
    Chen, Jack
    Laughlin, Steven K.
    Thakur, Kumar D.
    Lee, Wenlin
    Davis, Jan R.
    Cabrera, Ed J.
    Brugel, Todd A.
    VanRens, John C.
    Laufersweiler, Matthew J.
    Maier, Jennifer A.
    Sabat, Mark P.
    Golebiowski, Adam
    Easwaran, Vijay
    Webster, Mark E.
    De, Biswanath
    Zhang, George
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (05) : 1250 - 1253
12345